Holen Sie sich die Stockscreener-App
2.40
0.63%
0.010
Handel nachbörslich:
2.47
0.07
+2.92%
Schlusskurs vom Vortag:
$2.39
Offen:
$2.3301
24-Stunden-Volumen:
25,453
Relative Volume:
0.72
Marktkapitalisierung:
$10.45M
Einnahmen:
$1.02M
Nettoeinkommen (Verlust:
$-10.36M
KGV:
-0.3854
EPS:
-6.2265
Netto-Cashflow:
$-8.76M
1W Leistung:
+9.32%
1M Leistung:
-2.63%
6M Leistung:
-38.10%
1J Leistung:
-10.59%
1-Tages-Spanne:
$2.33
$2.46
1-Wochen-Bereich:
$2.1366
$2.46
52-Wochen-Spanne:
$1.99
$6.78
Sintx Technologies Inc Stock (SINT) Company Profile
Firmenname
Sintx Technologies Inc
Sektor
Branche
Telefon
801-839-3516
Adresse
1885 WEST 2100 STREET, SALT LAKE CITY, UT
Compare SINT vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SINT
Sintx Technologies Inc
|
2.42 | 10.32M | 1.02M | -10.36M | -8.76M | -6.2265 |
ABT
Abbott Laboratories
|
86.66 | 152.25B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
312.95 | 121.33B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
77.59 | 100.91B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
57.66 | 85.88B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.56 | 49.39B | 6.30B | 1.07B | 1.09B | 1.8406 |
Sintx Technologies Inc Stock (SINT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-13 | Eingeleitet | H.C. Wainwright | Buy |
| 2019-09-12 | Eingeleitet | Ascendiant Capital Markets | Buy |
Sintx Technologies Inc Aktie (SINT) Neueste Nachrichten
SiNtx Technologies (SINT) Attempts Recovery, Faces Key Test at $2.47 ResistanceTrader Community Signals - Newser
SiNtx Technologies (SINT) Stock Today: Drops -1.52% — Critical Support Levels 2026-05-21Low Risk Entry Stocks - Newser
H.C. Wainwright reiterates Buy on SINTX Tech stock, $10 target - Investing.com
H.C. Wainwright reiterates Buy on SINTX Tech stock, $10 target By Investing.com - Investing.com Nigeria
SINT Reiterated by HC Wainwright & Co. -- Price Target Maintained at $10 - GuruFocus
What's Next for SiNtx Technologies (SINT) at $2.20? 2026-05-20Impulse Wave - Newser
SINTX Technologies to present silicon nitride biomaterials progress at LD Micro Invitational. - Pluang
SINTX Technologies to Present at the LD Micro Invitational XVI Conference - TMX Newsfile
Medical ceramics firm SINTX to discuss implant progress at LD Micro - Stock Titan
SINTX Technologies Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Sintx Technologies, Inc. 1Q 2026: Revenue $380K, Net income $(2,821K) — 10-Q Summary - TradingView
Sintx Technologies, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
SiNtx Technologies (SINT) Fell -5.62% — Is a Recovery Ahead? 2026-05-15Crowd Signals - Newser
SINTX Technologies (NASDAQ: SINT) Q1 2026 loss and going concern warning - Stock Titan
SiNtx Technologies (SINT) Q4 2025 Earnings Miss by Significant: Key TakeawaysProfessional Trade Ideas - Newser
SiNtx Technologies, Inc.Common Stock (NQ: SINT - FinancialContent
SINT SiNtx Technologies posts narrow Q4 2025 EPS miss, shares rally 15.87 percent on positive investor sentiment.Competitive Advantage - newser.com
SINT Price Today: SiNtx Technologies, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
SINT Technical Analysis & Stock Price Forecast - Intellectia AI
SINT Forecast, Price Target & Analyst Ratings | SINTX TECHNOLOGIES INC (NASDAQ:SINT) - ChartMill
SiNtx Technologies (SINT) Stock: Buy, Sell, Hold? (+0.37%) 2026-04-18Undervalued Stocks - Xã Thanh Hà
Robert Ryan Elmore Net Worth (2026) - GuruFocus
H.C. Wainwright Initiates Sintx Technologies(SINT.US) With Buy Rating, Announces Target Price $10 - 富途牛牛
Sintx Technologies (SINT) president granted 4,910 common shares as equity award - Stock Titan
SINT Initiates Coverage On SINTX Technologies -- Price Target An - GuruFocus
Published on: 2026-04-14 02:01:43 - baoquankhu1.vn
Trend Report: Can Sintx Technologies Inc disrupt its industryBond Market & Real-Time Volume Analysis Alerts - baoquankhu1.vn
Sintx Technologies (NASDAQ:SINT) Given New $12.00 Price Target at Ascendiant Capital Markets - Defense World
SINT Maintains 'Buy' Rating; Target Price Adjusted to $12 by Asc - GuruFocus
Setup Watch: Can Sintx Technologies Inc stock double in the next yearMarket Trend Summary & Free Growth Oriented Trading Recommendations - baoquankhu1.vn
Total debt per share of SINTX Technologies, Inc. – LSE:0A8S - TradingView — Track All Markets
EBITDA per share of SINTX Technologies, Inc. – LSE:0A8S - TradingView
SINT Stock Analysis: SiNtx Technologies Inc. MedTech Play at $2.52 After 1.18% Daily Dip - Newser
Insider Sell: Can Sintx Technologies Inc disrupt its industryDip Buying & Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Earnings Update: What is the PEG ratio of Sintx Technologies IncMarket Risk Report & Technical Confirmation Alerts - baoquankhu1.vn
SINTX Technologies Provides Corporate Business Update Highlighting First Human Implant, Strategic Transformation, and Commercial Execution - Orthopedics This Week
SINTX completes first human implant, names new president By Investing.com - Investing.com Australia
Sintx Technologies 2025 10‑K: Revenue $1.018M, Net Loss $10.364M - TradingView
SINTX completes first human implant, names new president - Investing.com
After its first human foot implant, SINTX shifts to 2026 rollout - Stock Titan
Sintx Technologies (SINT) to Release Quarterly Earnings on Monday - Defense World
SINTX Technologies: Advanced Silicon Nitride Ceramics for Biomedical, Technical, and Antipathogenic Applications 72 - Minichart
SINTX Technologies Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Sintx Technologies, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - MarketScreener
SINTX Technologies (NASDAQ: SINT) outlines 2025 losses, cash and silicon nitride strategy - Stock Titan
SINTX completes first surgery with foot and ankle implant system By Investing.com - Investing.com India
SINTX Technologies Announces First-In-Human Surgery Using FDA-Cleared SINAPTIC® Foot & Ankle Implant - Orthopedics This Week
SINTX Technologies (SINT) Achieves Milestone with First Surgical Use of New System - GuruFocus
SINTX completes first surgery with foot and ankle implant system - Investing.com
Sintx Technologies announces first-in-human surgery using FDA-cleared Sinaptic® Foot & Ankle Implant - marketscreener.com
A new foot implant reaches its first patient after FDA clearance - Stock Titan
Finanzdaten der Sintx Technologies Inc-Aktie (SINT)
Umsatz
Nettogewinn
Free Cashflow
ENV
Sintx Technologies Inc-Aktie (SINT) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Lyons Christopher Michael | Director |
Feb 25 '26 |
Buy |
2.96 |
758 |
2,244 |
758 |
| MOYES JAY M | Director |
Feb 23 '26 |
Buy |
2.91 |
1,000 |
2,910 |
4,000 |
| Anderson Mark Lewis | Director |
Feb 18 '26 |
Buy |
3.02 |
3,000 |
9,060 |
18,000 |
| Honigblum Gregg R. | Chief Investment Officer |
Dec 08 '25 |
Buy |
4.26 |
8,200 |
34,896 |
201,067 |
| Honigblum Gregg R. | Chief Investment Officer |
Dec 05 '25 |
Buy |
3.93 |
65,000 |
255,350 |
139,000 |
| Honigblum Gregg R. | Chief Investment Officer |
Nov 07 '25 |
Buy |
3.19 |
10,000 |
31,900 |
74,000 |
| Olson Eric K. | President and CEO |
Oct 20 '25 |
Buy |
3.40 |
5,800 |
19,720 |
30,775 |
| MOYES JAY M | Director |
Aug 26 '25 |
Buy |
3.59 |
3,000 |
10,756 |
3,000 |
| Honigblum Gregg R. | Chief Investment Officer |
Aug 26 '25 |
Buy |
3.70 |
50,000 |
185,000 |
64,000 |
| Olson Eric K. | President and CEO |
Aug 22 '25 |
Buy |
3.58 |
10,475 |
37,470 |
24,975 |
1.35%
2.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):